ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 393

$738K Total Retail Price of All Prescriptions

Rank: 19 out of 393

492 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

29% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,903 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 621 368 S3 1 5
SIMVASTATIN 310 244 2 1
LEVOTHYROXINE SODIUM 309 277 3 3
ZOLPIDEM TARTRATE 282 224 4 11
LISINOPRIL 281 216 5 2
OMEPRAZOLE 272 190 6 6
CIPROFLOXACIN HCL 246 199 7 57
ALLOPURINOL 244 191 8 26
METOPROLOL TARTRATE 210 166 9 9
POTASSIUM CHLORIDE 204 172 10 20
AMLODIPINE BESYLATE 200 186 11 4
ATENOLOL 173 148 12 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 164 123 13 111
METFORMIN HCL 153 120 14 7
ATORVASTATIN CALCIUM 141 124 15 19
CLONIDINE HCL 139 113 16 50
FUROSEMIDE 135 110 17 8
DOXYCYCLINE HYCLATE 133 104 18 146
HYDROCHLOROTHIAZIDE 126 109 19 10
GABAPENTIN 125 75 20 15
METOPROLOL SUCCINATE 116 74 21 22
TRAZODONE HCL 116 67 21 47
ALPRAZOLAM 112 59 23 186
VENLAFAXINE HCL ER 100 76 24 177
PANTOPRAZOLE SODIUM 91 80 25 56
CYCLOBENZAPRINE HCL 87 39 R 26 109
TRAMADOL HCL 82 43 27 30
OXYCODONE HCL-ACETAMINOPHEN 81 50 S2 28 54
GLIPIZIDE 81 76 28 32
WARFARIN SODIUM 79 65 30 17
IBUPROFEN 78 39 31 55
LOSARTAN POTASSIUM 76 51 32 12
AZITHROMYCIN 71 52 33 35
FLUOXETINE HCL 64 30 34 37
LOVASTATIN 64 58 34 14
ALENDRONATE SODIUM 62 55 36 16
CARISOPRODOL 61 42 R 37 45
CLINDAMYCIN HCL 59 44 38 278
TAMSULOSIN HCL 58 48 39 25
FENTANYL 58 28 S2 39 135
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 42 41 24
DIOVAN 53 52 41 69
DIGOXIN 52 52 43 66
FLUTICASONE PROPIONATE 52 43 43 27
CITALOPRAM HBR 51 38 45 23
CARVEDILOL 51 44 45 21
LANTUS 50 39 47 73
CLOPIDOGREL 50 35 47 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.